Immunomodulation of voltage-dependent K+ channels in macrophages: molecular and biophysical consequences

被引:71
作者
Villalonga, Nuria [1 ]
David, Miren [2 ]
Bielanska, Joanna [1 ]
Vicente, Ruben [1 ]
Comes, Nuria [1 ]
Valenzuela, Carmen [2 ]
Felipe, Antonio [1 ]
机构
[1] Univ Barcelona, Inst Biomed, Dept Bioquim & Biol Mol, Mol Physiol Lab, E-08028 Barcelona, Spain
[2] Inst Invest Biomed Alberto Sols, E-28029 Madrid, Spain
关键词
HUMAN ALVEOLAR MACROPHAGES; GATED POTASSIUM CHANNELS; CENTRAL-NERVOUS-SYSTEM; MAMMALIAN-CELL LINES; GENE-EXPRESSION; ION CHANNELS; SUBUNIT EXPRESSION; HKV1.5; CHANNELS; UP-REGULATION; KV1.5;
D O I
10.1085/jgp.200910334
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Voltage-dependent potassium (K-v) channels play a pivotal role in the modulation of macrophage physiology. Macrophages are professional antigen-presenting cells and produce inflammatory and immunoactive substances that modulate the immune response. Blockage of K-v channels by specific antagonists decreases macrophage cytokine production and inhibits proliferation. Numerous pharmacological agents exert their effects on specific target cells by modifying the activity of their plasma membrane ion channels. Investigation of the mechanisms involved in the regulation of potassium ion conduction is, therefore, essential to the understanding of potassium channel functions in the immune response to infection and inflammation. Here, we demonstrate that the biophysical properties of voltage-dependent K+ currents are modified upon activation or immunosuppression in macrophages. This regulation is in accordance with changes in the molecular characteristics of the heterotetrameric K(v)1.3/K(v)1.5 channels, which generate the main K-v in macrophages. An increase in K+ current amplitude in lipopolysaccharide-activated macrophages is characterized by a faster C-type inactivation, a greater percentage of cumulative inactivation, and a more effective margatoxin (MgTx) inhibition than control cells. These biophysical parameters are related to an increase in K(v)1.3 subunits in the K(v)1.3/K(v)1.5 hybrid channel. In contrast, dexamethasone decreased the C-type inactivation, the cumulative inactivation, and the sensitivity to MgTx concomitantly with a decrease in K(v)1.3 expression. Neither of these treatments apparently altered the expression of K(v)1.5. Our results demonstrate that the immunomodulation of macrophages triggers molecular and biophysical consequences in K(v)1.3/K(v)1.5 hybrid channels by altering the subunit stoichiometry.
引用
收藏
页码:135 / 147
页数:13
相关论文
共 46 条
[1]   Kvβ1.3 reduces the degree of stereoselective bypivacaine block of Kv1.5 channels [J].
Arias, Cristina ;
Guizy, Miriam ;
David, Miren ;
Marzian, Stefanie ;
Gonzalez, Teresa ;
Decher, Niels ;
Valenzuela, Carmen .
ANESTHESIOLOGY, 2007, 107 (04) :641-651
[2]  
ATTARDI B, 1993, RECEPTOR CHANNEL, V1, P287
[3]   Ion channels in the immune system as targets for immunosuppression [J].
Cahalan, MD ;
Chandy, KG .
CURRENT OPINION IN BIOTECHNOLOGY, 1997, 8 (06) :749-756
[4]   Ion channels in microglia (brain macrophages) [J].
Eder, C .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 1998, 275 (02) :C327-C342
[5]   INFLUENCE OF CLONED VOLTAGE-GATED K+ CHANNEL EXPRESSION ON ALANINE TRANSPORT, RB+ UPTAKE, AND CELL-VOLUME [J].
FELIPE, A ;
SNYDERS, DJ ;
DEAL, KK ;
TAMKUN, MM .
AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 265 (05) :C1230-C1238
[6]   Microglia Kv1.3 channels contribute to their ability to kill neurons [J].
Fordyce, CB ;
Jagasia, R ;
Zhu, XP ;
Schlichter, LC .
JOURNAL OF NEUROSCIENCE, 2005, 25 (31) :7139-7149
[7]   Effects of propafenone and 5-hydroxy-propafenone on hKv1.5 channels [J].
Franqueza, L ;
Valenzuela, C ;
Delpón, E ;
Longobardo, M ;
Caballero, R ;
Tamargo, J .
BRITISH JOURNAL OF PHARMACOLOGY, 1998, 125 (05) :969-978
[8]  
FREEDMAN BD, 1992, J IMMUNOL, V149, P3784
[9]   Cell volume-sensitive sodium channels unregulated by glucocorticoids in U937 macrophages [J].
Gamper, N ;
Huber, SM ;
Badawi, K ;
Lang, F .
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2000, 441 (2-3) :281-286
[10]  
González T, 2001, J PHARMACOL EXP THER, V296, P573